» Articles » PMID: 34451829

Free Amino Acid Alterations in Patients with Gynecological and Breast Cancer: A Review

Overview
Publisher MDPI
Specialty Chemistry
Date 2021 Aug 28
PMID 34451829
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Gynecological and breast cancers still remain a significant health problem worldwide. Diagnostic methods are not sensitive and specific enough to detect the disease at an early stage. During carcinogenesis and tumor progression, the cellular need for DNA and protein synthesis increases leading to changes in the levels of amino acids. An important role of amino acids in many biological pathways, including biosynthesis of proteins, nucleic acids, enzymes, etc., which serve as an energy source and maintain redox balance, has been highlighted in many research articles. The aim of this review is a detailed analysis of the literature on metabolomic studies of gynecology and breast cancers with particular emphasis on alterations in free amino acid profiles. The work includes a brief overview of the metabolomic methodology and types of biological samples used in the studies. Special attention was paid to the possible role of selected amino acids in the carcinogenesis, especially proline and amino acids related to its metabolism. There is a clear need for further research and multiple external validation studies to establish the role of amino acid profiling in diagnosing gynecological and breast cancers.

Citing Articles

The Correlation Between Essential Amino Acid Tryptophan, Lysine, Phenylalanine and Chemotherapy of Breast Cancer.

Lv Y, Yang X, Song Y, Yang D, Zheng K, Zhou S Technol Cancer Res Treat. 2024; 23:15330338241286872.

PMID: 39435510 PMC: 11497521. DOI: 10.1177/15330338241286872.


Liquid chromatography-high-resolution mass spectrometry-based metabolomics revealing the effects of zearalenone and alpha-zearalenol on human endometrial cancer cells.

Marhaba M, Nagendla N, Anjum S, Ganneru S, Singh V, Pal S Toxicol Res (Camb). 2024; 13(5):tfae169.

PMID: 39417035 PMC: 11474235. DOI: 10.1093/toxres/tfae169.


Metabolic Fingerprinting of Serum and Seminal Plasma of Testicular Cancer Patients Using Raman Spectroscopy: A Pilot Study.

Lakpour N, Sadeghi M, Jafarzadeh N, Henkel R, Hajiparvaneh A, Fathi Z J Reprod Infertil. 2024; 25(1):3-11.

PMID: 39157284 PMC: 11330202. DOI: 10.18502/jri.v25i1.15193.


Unravelling genetic architecture of circulatory amino acid levels, and their effect on risk of complex disorders.

Abar L, Zuber V, Otto G, Tzoulaki I, Dehghan A NAR Genom Bioinform. 2024; 6(2):lqae046.

PMID: 38711861 PMC: 11071119. DOI: 10.1093/nargab/lqae046.


Upregulation of BRCA1 and 2 protein expression is associated with dysregulation in amino acids profiles in breast cancer.

Saleem T, Rizk M, Abdelhafez N, Sabra A, Radwan E Mol Biol Rep. 2024; 51(1):50.

PMID: 38165507 PMC: 10761515. DOI: 10.1007/s11033-023-09028-6.


References
1.
Abudula A, Rouzi N, Xu L, Yang Y, Hasimu A . Tissue-based metabolomics reveals potential biomarkers for cervical carcinoma and HPV infection. Bosn J Basic Med Sci. 2019; 20(1):78-87. PMC: 7029203. DOI: 10.17305/bjbms.2019.4359. View

2.
Strand E, Tangen I, Fasmer K, Jacob H, Halle M, Hoivik E . Blood Metabolites Associate with Prognosis in Endometrial Cancer. Metabolites. 2019; 9(12). PMC: 6949989. DOI: 10.3390/metabo9120302. View

3.
Gika H, Theodoridis G, Plumb R, Wilson I . Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics. J Pharm Biomed Anal. 2013; 87:12-25. DOI: 10.1016/j.jpba.2013.06.032. View

4.
Putri S, Yamamoto S, Tsugawa H, Fukusaki E . Current metabolomics: technological advances. J Biosci Bioeng. 2013; 116(1):9-16. DOI: 10.1016/j.jbiosc.2013.01.004. View

5.
Trousil S, Lee P, Pinato D, Ellis J, Dina R, Aboagye E . Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway. Cancer Res. 2014; 74(23):6867-77. DOI: 10.1158/0008-5472.CAN-13-2409. View